BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33529294
Number of visits today
7497
Number of downloads
16715381
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Cao L, Han Y, Pei L, Yue Z, Liu B, Cui J, Jia M, Wang H. A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer. Metabolites 2022;12:610. [DOI: 10.3390/metabo12070610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Vetrano E, Rinaldi L, Mormone A, Giorgione C, Galiero R, Caturano A, Nevola R, Marfella R, Sasso FC. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. Biomedicines 2023;11. [PMID: 36831004 DOI: 10.3390/biomedicines11020468] [Reference Citation Analysis]
2 Yue Z, Pei L, Meng G, Zhang A, Li M, Jia M, Wang H, Cao L. Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer. Metabolites 2023;13. [PMID: 36677015 DOI: 10.3390/metabo13010090] [Reference Citation Analysis]
3 Lee YT, Fujiwara N, Yang JD, Hoshida Y. Risk stratification and early detection biomarkers for precision HCC screening. Hepatology 2022. [PMID: 36082510 DOI: 10.1002/hep.32779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345